🇺🇸 FDA
Patent

US 10421773

Bone-selective osteogenic oxysterol bisphosphonate analogs

granted A61KA61K35/32A61P

Quick answer

US patent 10421773 (Bone-selective osteogenic oxysterol bisphosphonate analogs) held by The Regents of the University of California expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K35/32, A61P, A61P19/00, A61P19/10